baccaratlivedealer|金河生物:长期来看 化药产品成本仍具有下降空间

Date: 5个月前 (05-06)View: 54Comments: 0

Newsletter summary

Jinhe Biology: in the long run, there is still room for a decline in the cost of chemical products.BaccaratlivedealerJinhe Biology recently said at the performance presentation meeting thatBaccaratlivedealerThe cornerstone business of the company is veterinary medicine, is the leading enterprise of chlortetracycline in the world, accounting for more than 50% of the global market share, and the animal vaccine business is the companyBaccaratlivedealer.Baccaratlivedealer..

baccaratlivedealer|金河生物:长期来看 化药产品成本仍具有下降空间

Text of news flash

Jinhe Bio: in the long run, there is still room for a decline in the cost of chemical products. Jinhe Bio said recently at the performance presentation meeting that the company's cornerstone business is veterinary medicine and is the leading enterprise of chlortetracycline in the world. accounting for more than 50% of the global market share, animal vaccine business is the company's high-growth business, corn starch and environmental protection business as the company's chemical medicine supporting business. Can contribute to stable profits and cash flow every year. In terms of cost, corn and coal still have a downward trend in 2024. The prices of other raw and auxiliary materials, including soybean oil and yeast powder, have also declined to varying degrees since 2023. The company believes that the cost of chemical products still has room to decline in 2024, 2025 and in the long run.

Tags:

Prev: avetex503|五一档票房超15亿元: 总场次刷新纪录,《维和防暴队》夺冠
Next: crashbandicoot2017|燃气股盘中异动,南京公用涨停

Related articlesNo more
︿